Amneal Pharmaceuticals (AMRX) director reports 168,573-share transaction and updated holdings
Rhea-AI Filing Summary
BUCHI J KEVIN reported disposition transactions in this Form 4 filing.
Amneal Pharmaceuticals, Inc. director Kevin J. Buchi reported a derivative exercise/conversion transaction involving 168,573 shares of Class A Common Stock on 2026-08-11 at a weighted average price of $17.18 per share. According to the footnote, the shares were sold in multiple trades between $17.07 and $17.31 per share. Following this activity, 93,499 shares are held indirectly by a trust and a separate holding entry shows 75,077 shares held directly.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 168,573 shares
Net Sell
2 txns
Insider
BUCHI J KEVIN
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Class A Common Stock F1 | 168,573 | $17.18 | $2.90M |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 93,499 shares (Indirect, By Trust);
Class A Common Stock — 75,077 shares (Direct)
Footnotes (1)
- F1. The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.07 to $17.31 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
Key Figures
Shares in reported transaction: 168,573 shares
Weighted average price: $17.18 per share
Indirect holdings after transaction: 93,499 shares
+1 more
4 metrics
Shares in reported transaction
168,573 shares
Class A Common Stock derivative exercise/conversion on 2026-08-11
Weighted average price
$17.18 per share
Price for 168,573 shares, with trades from $17.07 to $17.31
Indirect holdings after transaction
93,499 shares
Class A Common Stock held indirectly by trust following the transaction
Direct holdings after transaction
75,077 shares
Class A Common Stock held directly in separate holding entry
Key Terms
weighted average price, Class A Common Stock, indirect ownership
3 terms
weighted average price financial
"The price included in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Class A Common Stock financial
"security_title: Class A Common Stock for the reported transaction."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
indirect ownership financial
"Indirect ownership is indicated as By Trust for 93,499 shares."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transaction did AMRX director Kevin J. Buchi report on this Form 4?
Kevin J. Buchi reported a derivative exercise/conversion involving 168,573 shares of Amneal Class A Common Stock on 2026-08-11, with the transaction coded as an exercise or conversion of a derivative security and marked as a disposition.
Does the AMRX Form 4 note that the reported prices are weighted averages?
Yes. A footnote explains that the $17.18 figure is a weighted average price, and that the 168,573 shares were sold in multiple transactions between $17.07 and $17.31, with trade-by-trade detail available on request.